SHINGRIX: Coverage information

SHINGRIX: Private coverage & public funding information

Ontario publicly funded shingles (herpes zoster) program1

Updated: August 2022.

Overview: SHINGRIX is covered on the Ontario publicly funded shingles immunization program for Ontario seniors aged 65 to 70 years. Please note: As a result of the COVID-19 pandemic and response activities, individuals born in 1949 to 1952 who missed the opportunity to receive the publicly funded shingles vaccine, are eligible to receive SHINGRIX and complete the 2-dose series by December 31, 2023.

For complete eligibility criteria, click the button below.

Access: Eligible individuals are able to receive SHINGRIX through their primary healthcare provider.

Learn more

Veteran Affairs Canada (VAC)2

Updated: January 2021.

Overview: SHINGRIX is covered on the Veteran Affairs Canada Federal Plan for all members 50 years of age and older.

Access: Eligible members require a prescription from their health professional authorized to prescribe pharmaceuticals.

Learn more

First Nations Health Authority (FNHA)3

Updated: February 2021.

Overview: SHINGRIX is covered on the First Nations Health Authority program for First Nations Elders who are 65 years old and older.

Access: The SHINGRIX vaccine can be prescribed by a physician or nurse practitioner, or obtained directly from the pharmacist.

Learn more

Non-Insured Health Benefits (NIHB) program4

Updated: January 2021.

Overview: SHINGRIX is covered on the Non-Insured Health Benefits program for clients between 65 and 70 years of age. 

Access: A prescription from a licensed practitioner is required for SHINGRIX to be processed as a benefit.

Learn more

Private insurance

The cost of SHINGRIX may be covered by your patient’s private insurance. They can contact their insurance provider and give the DIN (drug identification number) below to find out.

SHINGRIX DIN: 02468425.

Prince Edward Island publicly funded shingles (herpes zoster) program5

Updated: January 2022.

Overview: SHINGRIX is covered by the provincial government for Prince Edward Island seniors aged 65 and older.

Access: Eligible individuals are able to receive SHINGRIX through their pharmacist.

Learn more

Yukon publicly funded shingles (herpes zoster) program6

Updated: December 2021.

Overview: SHINGRIX is covered by the publicly funded shingles vaccine program for Yukoners aged 65 to 79 years.

Access: Eligible individuals are able to receive SHINGRIX at Whitehorse pharmacies.

Learn more

References:

  1. Ontario Ministry of Health. Guidance for routine & catch-up immunization services. August 2022. Available at: https://health.gov.on.ca/en/pro/programs/immunization/docs/Guidance_for_Routine_CatchUp_Immunization_Services.pdf. Accessed November 30, 2022.
  2. Veteran Affairs Canada. Details: Drug 02468425: SHINGRIX suspension 50mcg/0.5mL. Available at: https://www.veterans.gc.ca/eng/financial-support/medical-costs/treatment-benefits/poc10/search/form_detail/02468425. Accessed November 30, 2022.
  3. First Nations Health Authority. First Nations Health Authority Expanding Elders Coverage of Shingrix® Shingles Vaccine. January 29, 2021. Available at: https://www.fnha.ca/benefits/health-benefits-news/first-nations-health-authority-expanding-elders-coverage-of-shingrix-shingles-vaccine. Accessed November 30, 2022.
  4. Indigenous Services Canada. Non-Insured Health Benefits (NIHB) Program: New Product Listing - Shingrix. January 11, 2021. Available at: https://nihb.express-scripts.ca/NIHBProvider/benefits/pharmacy?page=pharmacy-bulletins&benefit=pharmacy. Accessed November 30, 2022.
  5. Prince Edward Island Canada. Free shingles vaccine for Island seniors in January 2022. Available at: https://www.princeedwardisland.ca/en/news/free-shingles-vaccine-for-island-seniors-in-january-2022.
  6. Government of Yukon. Shingles vaccine program expanded. Available at: https://yukon.ca/en/news/shingles-vaccine-program-expanded. Accessed November 30, 2022.
  7. Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008;57(RR-5):1-30.
  8. Public Health Agency of Canada. An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI) – Updated Recommendations on the Use of Herpes Zoster Vaccines. Ottawa, Ontario: Public Health Agency of Canada; June 2018. Available at: https://www.canada.ca/en/services/health/publications/healthy-living/updated-recommendations-use-herpes-zoster-vaccines.html. Accessed November 30, 2022.

Trademarks are owned by or licensed to the GSK group of companies.

©2022 GSK Group of Companies or its licensor.

10661 | 06/23